<DOC>
	<DOCNO>NCT02036372</DOCNO>
	<brief_summary>The incidence diabetes mellitus type II increase . More patient need surgery diabetes mellitus type II . Despite enormous amount glucose lowering protocol proven negative effect hyperglycaemia . There evidence optimal glucose lower protocol . This study investigate optimal intraoperative treatment algorithm lower glucose patient diabetes mellitus type 2 undergoing non-cardiac surgery , compare intraoperative glucose-insulin-potassium infusion ( GIK ) , insulin bolus regimen ( BR ) GLP-1 ( liraglutide , LG ) treatment .</brief_summary>
	<brief_title>Perioperative Insulin , GIK GLP-1 Treatment Diabetes Mellitus</brief_title>
	<detailed_description>Diabetes mellitus associate poor outcome surgery . The prevalence diabetes hospitalise patient 40 % , mean anaesthesiologist encounter diabetes patient operate room daily basis . Multiple protocols perioperative glucose regulation develop , range intravenous glucose-insulin-potassium infusion subcutaneous bolus regimen . Despite abundance publish glucose lowering protocol proven negative effect intraoperative hyperglycaemia diabetes , evidence regard optimal intraoperative glucose lower treatment . Recently , incretins introduce low blood glucose . The main hormone incretin system glucagon-like peptide-1 ( GLP-1 ) . GLP-1 increase insulin decrease glucagon secretion glucose-dependent manner , result low incidence hypoglycaemia . This study investigate first time optimal intraoperative treatment algorithm lower glucose patient diabetes mellitus undergo non-cardiac surgery . Objective : This study investigate optimal intraoperative treatment algorithm lower glucose patient diabetes mellitus type 2 undergoing non-cardiac surgery , compare intraoperative glucose-insulin-potassium infusion ( GIK ) , insulin bolus regimen ( BR ) GLP-1 ( liraglutide , LG ) treatment .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Signed informed consent know diabetes mellitus type II &gt; 3 month age 1875 year schedule elective noncardiac surgery Daily insulin dosage &gt; 1 IU/kg body weight Oral corticosteroid use Planned daycare ( ambulant ) surgery Planned ICU stay postoperatively Planned bowel surgery History chronic pancreatitis idiopathic acute pancreatitis Impaired renal function define serumcreatinine ≥ 133 μmol/L male ≥ 115 μmol/L female Females child bear potential pregnant , breastfeed intend become pregnant use adequate contraceptive method ( adequate contraceptive measure require local law practice ) Known suspect allergy trial product ( ) relate product Any condition local investigator feel would interfere trial participation evaluation result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>glucose</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>perioperative</keyword>
</DOC>